[1]
“HeartMate 3 LVAD as Destination Therapy can change Concept of Advanced Heart Failure Management: A Systematic Review and Meta Analysis in terms of Survival benefits and limitations”, VER, vol. 8, no. 16s, pp. 79–93, Dec. 2025, doi: 10.64149/J.Ver.8.16s.79-93.